Submitted by RT
COVID Vaccines Increase Menstrual Irregularities Thousandfold, Foetal Abnormalities Hundredfold: Doctors’ VAERS Analysis…
Enrico Trigoso, The Epoch Times, July 1, 2022: New disturbing pharmacovigilance signals from VAERS surrounding the use of the COVID ‘vaccines’ on women of reproductive age prompted a group of doctors to call for a ban on the Gene Therapy COVID-19’ vaccines’. Over the past two weeks Dr James Thorp, a Maternal-Foetal medicine expert, painstakingly analysed and verified the most recent Vaccine Adverse Event Reporting System (VAERS) data related to COVID-19 ‘vaccines’ and compared them to the Influenza ‘vaccines.’ His findings are listed below:
Abnormal uterine bleeding (menstrual irregularity) is 1000-fold greater …
Miscarriages are 50-fold greater … Foetal chromosomal abnormalities are 100-fold greater … Foetal malformation is 50-fold greater … Foetal cystic hygroma (a major malformation) is 90-fold greater … Foetal cardiac disorders are 40-fold greater … Foetal arrhythmia is 50-fold greater … Foetal cardiac arrest is 200-fold greater … Foetal vascular mal-perfusion is a 100-fold greater … Foetal growth abnormalities are 40-fold greater … Foetal abnormal surveillance tests are 20-fold greater … Foetal placental thrombosis is 70-fold greater.
Christiane Northrup, MD, a fellow of the American College of Obstetrics and Gynaecology, also stands by the analysis. “Having been on the front lines of the *DES disaster as a young OB/GYN, I am astounded that we are repeating the same kind of mistake but on a far more devastating level. COVID-19 shots must be stopped immediately in all pregnant women before further damage is done to the next generation,” Northrup told The Epoch Times.
*Diethylstilbestrol (DES) is a synthetic form of the female hormone Oestrogen. It was prescribed to pregnant women between 1940 and 1971. In 1971, researchers linked prenatal (in utero) DES exposure to a type of cancer of the cervix and vagina called Clear Cell Adenocarcinoma in a small(?) group of women. Soon after, the Food and Drug Administration (FDA) notified health care providers throughout the country that DES should not be prescribed to pregnant women. The drug continued to be prescribed to pregnant women in Europe until 1978. DES is now known to be an endocrine-disrupting chemical, one of a number of substances that interfere with the endocrine system to potentially cause cancer, birth defects, and other developmental abnormalities.